Early research (Phase 1)Study completedNCT05858710What this trial is testingStudy of DPPG2-TSL-DOX Combined With Hyperthermia in Soft Tissue SarcomaWho this might be right forSarcoma, Soft Tissue Thermosome GmbH 8
Testing effectiveness (Phase 2)Ended earlyNCT03422679What this trial is testingStudy of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological MalignanciesWho this might be right forBreast CancerColorectal CancerAdenoid Cystic Carcinoma+5 more Cellestia Biotech AG 79
Not applicableStudy completedNCT04560270What this trial is testingCIrculating Tumor DNA for Monitoring Response to First Line Chemotherapy in Unresectable PANcreatic CancerWho this might be right forPancreatic CancerCirculating Tumor DNAKRAS Mutation-Related Tumors Poitiers University Hospital 69
Testing effectiveness (Phase 2)Study completedNCT01427881What this trial is testingCyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+65 more Fred Hutchinson Cancer Center 43
Early research (Phase 1)Active Not RecruitingNCT01953900What this trial is testingIC9-GD2-CAR-VZV-CTLs/Refractory or Metastatic GD2-positive Sarcoma and NeuroblastomaWho this might be right forOsteosarcomaNeuroblastoma Baylor College of Medicine 26
Testing effectiveness (Phase 2)Study completedNCT00028730What this trial is testingTotal-Body Irradiation and Chemotherapy Followed By Donor Bone Marrow Transplant in Treating Young Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMyelodysplastic Syndromes+1 more Memorial Sloan Kettering Cancer Center 25
Early research (Phase 1)Looking for participantsNCT06440005What this trial is testingEvaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid TumorsWho this might be right forCancerAdvanced CancerLocally Advanced Carcinoma+8 more Angiex, Inc. 80
Testing effectiveness (Phase 2)Study completedNCT01459484What this trial is testingABCB1/P-glycoprotein Expression as Biologic Stratification Factor for Patients With Non Metastatic OsteosarcomaWho this might be right forOsteosarcoma Italian Sarcoma Group 225
Testing effectiveness (Phase 2)Study completedNCT02727387What this trial is testingProtocol for the Treatment of Metastatic Ewing SarcomaWho this might be right forEwing's Sarcoma (ES) Italian Sarcoma Group 155
Testing effectiveness (Phase 2)Active Not RecruitingNCT03414229What this trial is testingEpacadostat, an IDO1 Inhibitor, in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced SarcomaWho this might be right forSarcoma Memorial Sloan Kettering Cancer Center 30
Testing effectiveness (Phase 2)Ended earlyNCT04260802What this trial is testingEvaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic CancersWho this might be right forCancerNeoplasmsMetastatic Cancer+16 more Ocellaris Pharma, Inc. 73
Early research (Phase 1)WithdrawnNCT02915172What this trial is testingLenvatinib and Capecitabine in Patients With Advanced MalignanciesWho this might be right forAdvanced CancerMalignant Neoplasm of BreastMalignant Neoplasms of Bone and Articular Cartilage+11 more M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00276692What this trial is testingIrinotecan in Treating Patients With Newly Diagnosed Ewing's SarcomaWho this might be right forSarcoma Children's Cancer and Leukaemia Group 35
Large-scale testing (Phase 3)Study completedNCT00045292What this trial is testingValacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell TransplantationWho this might be right forCancer Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00112463What this trial is testingDepsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue SarcomaWho this might be right forAdult Alveolar Soft-part SarcomaAdult AngiosarcomaAdult Epithelioid Sarcoma+17 more National Cancer Institute (NCI) 40
Early research (Phase 1)Study completedNCT02015416What this trial is testingTrial of NY-ESO-1 With GLA-SE in Patients With Unresectable or Metastatic CancerWho this might be right forMelanomaOvarian CancerSarcoma+2 more Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 13
Early research (Phase 1)Study completedNCT00638898What this trial is testingBusulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid TumorWho this might be right forSolid TumorAdult Central Nervous System Germ Cell TumorAdult Rhabdomyosarcoma+27 more City of Hope Medical Center 25
Not applicableLooking for participantsNCT02012699What this trial is testingIntegrated Cancer Repository for Cancer ResearchWho this might be right forPancreatic CancerThyroid CancerLung Cancer+47 more University of Nebraska 999,999
Large-scale testing (Phase 3)Study completedNCT00346164What this trial is testingObservation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue SarcomaWho this might be right forAdult Alveolar Soft-part SarcomaAdult AngiosarcomaAdult Epithelioid Sarcoma+26 more Children's Oncology Group 588
Not applicableEnded earlyNCT00957736What this trial is testingChronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell TransplantWho this might be right forCancer Vanderbilt-Ingram Cancer Center 252